Aceragen Price Prediction

ACGNDelisted Stock   0.75  0.23  23.47%   
As of today, the value of RSI of Aceragen's share price is approaching 49. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Aceragen, making its price go up or down.

Oversold Vs Overbought

49

 
Oversold
 
Overbought
The successful prediction of Aceragen's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Aceragen, which may create opportunities for some arbitrage if properly timed.
Using Aceragen hype-based prediction, you can estimate the value of Aceragen from the perspective of Aceragen response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aceragen to buy its stock at a price that has no basis in reality. In that case, they are not buying Aceragen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Aceragen after-hype prediction price

    
  USD 0.75  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Intrinsic
Valuation
LowRealHigh
0.710.710.83
Details
Naive
Forecast
LowNextHigh
0.750.750.75
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.710.981.26
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aceragen. Your research has to be compared to or analyzed against Aceragen's peers to derive any actionable benefits. When done correctly, Aceragen's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Aceragen.

Aceragen After-Hype Price Prediction Density Analysis

As far as predicting the price of Aceragen at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aceragen or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aceragen, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Aceragen Estimiated After-Hype Price Volatility

In the context of predicting Aceragen's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aceragen's historical news coverage. Aceragen's after-hype downside and upside margins for the prediction period are 0.75 and 0.75, respectively. We have considered Aceragen's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.75
0.75
After-hype Price
0.75
Upside
Aceragen is very steady at this time. Analysis and calculation of next after-hype price of Aceragen is based on 3 months time horizon.

Aceragen Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Aceragen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aceragen backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aceragen, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
3 Events / Month
13 Events / Month
In about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.75
0.75
0.00 
0.00  
Notes

Aceragen Hype Timeline

Aceragen is presently traded for 0.75. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Aceragen is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Aceragen is about 0.0%, with the expected price after the next announcement by competition of 0.75. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Aceragen Related Hype Analysis

Having access to credible news sources related to Aceragen's direct competition is more important than ever and may enhance your ability to predict Aceragen's future price movements. Getting to know how Aceragen's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aceragen may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ADXNAddex Therapeutics(0.52)4 per month 0.00 (0.06) 9.74 (7.15) 29.35 
ERYPErytech Pharma SA 0.02 3 per month 0.00 (0.03) 12.68 (8.25) 46.27 
SNGXSoligenix 0.13 7 per month 4.80  0  8.86 (7.24) 47.05 
ATXIAvenue Therapeutics 0.20 4 per month 0.00 (0.09) 6.81 (6.67) 23.22 
AKTXAkari Therapeutics PLC(0.05)6 per month 0.00 (0.19) 10.10 (12.59) 47.27 
ARMPArmata Pharmaceuticals(0.1)3 per month 0.00 (0.04) 6.19 (7.05) 33.83 
ANEBAnebulo Pharmaceuticals(0.02)5 per month 0.00 (0.01) 8.61 (11.48) 76.00 
SCPSScopus Biopharma 0.00 0 per month 17.13  0.01  35.42 (24.69) 94.02 
PCSAProcessa Pharmaceuticals 0.03 3 per month 0.00 (0.09) 7.26 (7.76) 20.99 
NLTXNeoleukin Therapeutics(0.14)1 per month 0.00 (0.08) 4.05 (3.53) 27.84 
SNTISenti Biosciences 2.91 2 per month 3.42  0.11  7.35 (7.36) 29.17 
HILSHillstream Biopharma 0.03 3 per month 0.00 (0.06) 8.33 (7.89) 113.15 
SABSSAB Biotherapeutics 0.08 7 per month 6.23  0.01  13.50 (11.25) 45.73 
QNRXQuoin Pharmaceuticals Ltd(0.01)8 per month 6.53  0.04  17.65 (9.68) 74.46 
COCPCocrystal Pharma(0.03)5 per month 3.39  0.03  6.51 (6.19) 28.01 
IBIOIbio Inc(0.03)3 per month 3.53  0.12  8.08 (6.47) 30.48 
BPTHBio Path Holdings(0.16)7 per month 0.00 (0.05) 6.67 (7.76) 51.22 
TPSTTempest Therapeutics(0.47)4 per month 0.00 (0.10) 6.38 (8.53) 29.55 
RNXTRenovoRx(0.06)4 per month 3.96  0.05  7.55 (6.20) 40.06 
ACRVAcrivon Therapeutics, Common(0.60)5 per month 0.00 (0.12) 6.90 (7.65) 22.84 
ACXPAcurx Pharmaceuticals LLC 0.01 6 per month 0.00 (0.26) 3.85 (7.04) 28.75 

Aceragen Additional Predictive Modules

Most predictive techniques to examine Aceragen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aceragen using various technical indicators. When you analyze Aceragen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aceragen Predictive Indicators

The successful prediction of Aceragen stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aceragen, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aceragen based on analysis of Aceragen hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aceragen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aceragen's related companies.

Story Coverage note for Aceragen

The number of cover stories for Aceragen depends on current market conditions and Aceragen's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aceragen is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aceragen's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Aceragen Short Properties

Aceragen's future price predictability will typically decrease when Aceragen's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aceragen often depends not only on the future outlook of the potential Aceragen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aceragen's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.3 M
Cash And Short Term Investments12 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Consideration for investing in Aceragen Stock

If you are still planning to invest in Aceragen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aceragen's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets